Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Correlia Biosystems, a US-based immunoassay technology producer, has closed a $7m series A round involving the Regents of the University of California. The round was led by Neotribe Ventures and backed by Cota Capital alongside undisclosed additional investors. The funding is intended to facilitate the commercial launch of Correlia’s first product, a miniaturised assay known…

The rest of this content is only accessible to University Venturing: News, Data and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.